Pharmacotherapy Flashcards
BMI indications for rx & surg
Rx:
27 w complications
30
Surg:
35 w compl
40
Benefits of modest wt loss @ 5-10% and >10%
5-10%:
-improved lipds
-↓ CVD risk
-↓ BP
-↑ insulin sens & glycemic control in T2DM
-↓ progression from pre-DM to T2DM
> 10%:
-more improvement in above
-↓ NAFLD/NASH and fibrosis
-improved OSA
-joint paint/arthritic conditions
-PCOS & fertility
FDA-approved for LONG-term use
Phentermine/Topiramate ER
Naltrexone/Bupropion
Orlistat
Semaglutide
Liraglutide
Setmelanotide
FDA-approved for SHORT-term use
Phentermine & similars:
Diethylpropion
Phendimetrazine
Benphetamine
OFF-LABEL use AOM’s for LONG-term (7)
Topiramate
Zonisamide
Bupropion
Other GLP1-RA
Metformin
Amyling agonist
SGLT2 inhibitors
Age cutoffs
Trade names:
Orlistat
Xenical
Alli
Trade names:
Phentermine/Topiramate ER
Qsymia
Trade names:
Naltrexone/Bupropion
Contrave
Trade names:
Liraglutide
Saxenda
Trade names:
Semaglutide
Wegovy
Trade names:
Setmelanotide
Imcivree
Trade names:
Phentermine
Lomaira
Adipex
Trade names:
Diethylpropion
Phendimetrazine
Benzphetamine
Diethylpropion:
…Tenuate (Tenuate Dospan)
Phendimetrazine:
…Bontril
Benzphetamine
…Regimex
Phentermine:
Dosage
Mech
Contraind
Adverse rxns
Pharmacokinetics
Dosage:
-most commonly 15-37.5 mg daily
-8, 15, 30, and 37.5 mg scored capsules
Mech:
-sympathomim amine –> hypoth NE release, other CNS effects
Contraind:
-Preg
-acute CHD
-closed angle glaucoma
Adverse rxns:
**dry mouth
**MAOI, EtOH, adren nerve block
-insomnia
-brux
-palpitations
-constip
-diff urinating
-HA
-irrit
-dysphoria
-change in libido
* NO e/o addiction or withdrawal
Pharmacokinetics:
-urinary excretion (careful w renal impairment!)
-t 1/2 is 7-20 hrs
Randos:
Diethylpropion
Phendimetrazine
Benzphetamine
-Dosages
-Usage notes
-DEA sched
-Excretion
Dosages:
-D: 25 (75 ER) TID
-P: 35 (105 ER) TID
-B: 25-50 once a day, up to TID
Usage notes:
-D: TID, short acting 4-6 hrs, weaker than phen
-P: TID 1 hr before meals, sometimes AM phenT w PM phenD, weaker than phen
DEA sched:
-B: IV
-P: III
*D&P excreted by urin ?B
Sympathomim contrainds
Preg (or planning)- X
Breastfeeding- X
Current ADR
Advanced/Sx CAD
Uncontrolled HTN
Hyperthyroid
Close angle glaucoma
Severe anxiety
Uncontrolled mental health
Sympathomim interactions
MAOI <14 days
Anesthesia
Caffeine
EtOH
Sympathomim SE
Dry mouth (muc erosions 1/1000)
Dia/Const
Diff sleeping
Dz
Dysgeu
↓ libido
CNS stim –> restless
Glaucoma, IOP
HA
↑ BP
↑ HR
Palps
EKG alerts while on sympathomim
-E/o ischemia/infarct
-LBBB, esp new
-multifocal PVCs
-QTc prolongation (tx w K, Mg)
…>460 kids, 450 M, 470 F
*LAD(?) common in obesity, reversed w wt loss
Phentermine/Topiramate ER
Dosage
Mech
Contraind
Adverse rxns
Pharmacokinetics
Dosage:
-AM 3.75/23 mg x 14 d
-then ↑ to 7.5/46 mg x 12 wks
…if <3%,
↑ again to 11.25/69 mg x 14 d
-then 15/92 mg (full strength) x 12 wks
…D/C if <5% @ 12 wks, but TITRATE QOD at least 7 days bc sz risk
Mech:
-Phen is sympathomim amine
–> catechol (NE) in hypothalamus ↓ app & food intake
-Top mech unknown, possibly GABA effects on appetite and satiety or by –| CANH
Contraind:
(see individ)
Adverse rxns:
(see individ)
Pharmacokinetics:
-Phen met liver and excreted by kids
-Top excreted by kids
Phentermine/Topiramate ER
Contrainds
Sx CAD
Active mania
Uncontr HTN
Closed angle glaucoma
Preg
Ca ox kid stones
MAOI in past 14 days
** monitor for preg w monthly UPT and document 2 FORMS of contraception
EKG alerts while on sympathomim
-E/o ischemia/infarct
-LBBB, esp new
-multifocal PVCs
-QTc prolongation (tx w K, Mg)
…>460 kids, 450 M, 470 F
*LAD(?) common in obesity, reversed w wt loss
Phentermine/Topiramate ER
Adverse rxns
Common:
Paresthesias
Dysgeusia
Dz
Insom
Constipation
Dry mouth
Attn disturbance
Serious:
*nephrolithiasis
metbolic acidosis
acute angle closure glaucoma
Depression & SI
Orlistat:
Dosage
Mech
Contraind
Adverse rxns
Pharmacokinetics
Dosage:
-60-120 TID w meals
Mech:
-Lipase inh –| 30% fat abs
Contraind:
-Preg
-Chronic malabs
-Cholestasis
Adverse rxns:
-diarrhea, oily stools
-fecal incont
-RARE hepatotox
-fat sol vit def
-↑ urinary oxalate
Pharmacokinetics:
-likely mainly within GI wall
-minimal systemic absorption
Naltrexone/Bupropion HCL ER
Dosage
Mech
Contraind
Adverse rxns
Pharmacokinetics
Dosage:
-8/90 mg, Titrate up over 4 wks
1. 1 AM
2. 1 AM + 1 PM
3. 2 AM + 1 PM
4. 2 + 2
-D/C if <5% wt loss @ 12 wks
Mech:
-Natrexone is opioid antag
-Bup: weak –| reuptake of NE & DA
-both may work in hypoth & mesolimp/DA circuit to ↓ app & reward
Contraind:
-Uncontrolled HTN
-Sz d/o
-AN / bulimia
-abrupt d/c of EtOH, benz/barbs, anti-eps
-chronic opiod use
-MAOI within 14 d
Adverse rxns:
-Bup & metabs –| CYP2D6
-N/V
-constip
-HA
-dz
-insomnia
-dry mouth
-diarrhea
SERIOUS:
-worsening depression & SI
-hepatotoxicity
-sz
Pharmacokinetics:
-Bup: ext metabolized into active metabolites, 87% metabs excreted by kids
-Nal: excreted by kids
Liraglutide & Semaglutide:
Dosage
Mech
Contraind
Adverse rxns
Pharmacokinetics
Dosage (for obesity):
Lira: 3 mg daily
Sema: 2.4 mg WEEKLY
Mech:
-hypothalamus ↓ intake, ↑ satiety
-improves glucose metab
-?↓ gastric emptying
Contraind:
-med thyr CA (black box lira)
-MEN2
-preg
Adverse rxns:
** acute pancreatitis
** acute gb dz (?2/2 wt loss)
** hypoglycemia esp. w insulin/secretagogues
** suicidal
** N/V –> AKI ** hydrate
-C/D
-HA
-dz
-fatigue
-↑ HR
-dyspepsia / abd pain
-↑ lipase
-high fat foods –> nausea
Pharmacokinetics:
Lira:
-SC lira only 55% bioavailable
-endog metab, no specific organ
-intact lira not excreted
Sema:
-SC sema 89% bioavail
-metab following proteolytic cleavage, beta ox of FA sidechain
-98% bound to alb
-excr via urine and feces
Lira dosing
Over 5 wks:
… 0.6 mg x 7 d
… +0.6 mg per wk
… 3 mg maintenance dose
Consider D/C if <4% wt loss @ 16 wks
Sema dosing
Over 5 MONTHS:
…0.25 mg x 4 wks
…then 0.5, 1.0, 1.7, 2.4 maint
If 2.4 not tol, decrese to 1.7 for up to 4 wks. If 2.4 still not tolerated then D/C
Setmelanotide:
Dosage
Mech
Contraind
Adverse rxns
Pharmacokinetics
Dosage: (DAILY SC)
6-11 yo:
1 mg x 2 wks
…titrate to 2 mg
12-adult:
2 mg x 2 wks
…titrate to 3 mg
Mech:
–> MC4R pathway in pts w def in POMC, PCSK-1, LEPR
… ↓ hunger, ↑ EE
Contraind:
none
d/c in preg unless ben>risk?
Adverse rxns:
-spont erection
-Depr & SI
-** skin pigmentation & darkening of nevi
-most commonly: inj site pain & pig, GI (n/v/d/pain), HA, back pain, fatigue
Pharmacokinetics:
-T 1/2 11 hrs
-broken down into smaller peptides, 39% excr unchnaged in urine